Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ForSight Robotics has developed the ORYOM™ Platform—the world’s first robotic system designed specifically for cataract and other ophthalmic surgeries. The company has completed hundreds of successful preclinical procedures on animal models. As of June 2025, it plans to initiate its first human clinical trials in cataract surgery within the year. The platform leverages AI-driven algorithms and advanced robotics to deliver highly precise eye surgeries with improved ergonomics for surgeons. No published human clinical results yet.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ForSight Robotics.